imiquimod has been researched along with cimifugin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Li, J; Liu, A; Tu, Y; Wang, Q; Zhang, B; Zhao, W | 1 |
1 other study(ies) available for imiquimod and cimifugin
Article | Year |
---|---|
Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Chromones; Cytokines; Disease Models, Animal; HaCaT Cells; Humans; Imiquimod; Intercellular Adhesion Molecule-1; Keratinocytes; Male; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; NF-kappa B; Oxidative Stress; Phosphorylation; Psoriasis; Signal Transduction; Skin | 2020 |